A DNA vaccine is a small, circular DNA plasmid that encode one or more protein antigens under the control of a promoter to produce immune response against disease. DNA vaccines are basically the third generation vaccines that are specifically designed to overcome the unsought properties of conventional vaccines. The increasing vulnerability of population to infectious diseases and increasing number of antibiotics resistant pathogens have created the need for effective and low-cost vaccination, which would provide long lasting immunity. DNA vaccines have potential advantages over traditional methods, e.g., low risk of infection, easy transportation and stability at room temperature. The global DNA vaccines market is experiencing rapid growth owing to the factors such as the property of specific antigen targeting, reduced risk of infection compared to conventional vaccines and improved stability. Moreover, relative ease of large-scale manufacturing compared to traditional approach and less storage requirement are some of the key market drivers.
According to World Health Organization, ~18 million people die due to the unavailability of effective treatment for infectious disease, which demonstrate global burden of infectious disease. Thus, the increasing burden of these diseases reveals the opportunity for DNA vaccines manufacturers. Moreover, rapid development in the field of molecular biology, immunology and DNA synthesis would further drive the growth of this market. Other factors such as inefficient drug therapies and increased microbial resistance to existing ‘antimicrobials and antibiotics’ treatments would likely to create the demand for DNA vaccines in near future.
The global DNA vaccines market is segmented based on type, technology, application, end user and geography. Based on type, the market is further segmented into human DNA vaccines and animal DNA vaccines. Based on technology, the DNA vaccines market is further segmented into DNA vaccine technology and DNA delivery technology. Based on applications, the market is further segmented into human disease i.e., oncology, infectious disease, allergies and others; and veterinary diseases i.e. Canine Melanoma, Leishmaniasis, Equine West Nile Virus, and others. Based on end user, the market is segmented into human health, animal health and research application. Based on geography, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. Companies profiled in the report includes Sanofi Aventis, Pfizer Pharmaceuticals, Novartis AG, Merck & Co., GlaxoSmithKline Inc., Advance Bioscience Laboratories Inc., Indian Immunologicals Ltd., Xenetic Biosciences Inc., QED Biosciences Inc..
KEY MARKET BENEFITS
KEY MARKET SEGMENTS
The global DNA vaccines market is segmented as below:
Global DNA vaccines market - By Types
Global DNA vaccines market - By Technology
Global DNA vaccines market- By Application
Global DNA vaccines market- by End User
Global DNA vaccines market- By Geography
SIMILAR MARKET STUDIES
This report provides an overview of the Spanish blood banking market, including sales and market shares of leading suppliers of blood typing, grouping and infectious disease screening/NAT tests, as well as test volume and sales forecasts by market segment.Table of ContentsBusiness EnvironmentMarket StructureMarket Size, Growth and Major Suppliers’ Sales and ...
June 2016 | $0 | View Details >>
The Global Plasma Therapeutics Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Plasma Therapeutics market. First, the report provides a basic overview of the Plasma Therapeutics industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed ...
June 2016 | $4000 | View Details >>
Complete report $19,700. DataPack (test volumes, sales forecasts, supplier shares) $12,800.This new 1273-page comprehensive five-country report from VPGMarketResearch is designed to help current suppliers and potential market entrants identify and evaluate the major business opportunities emerging in the European molecular diagnostics market during the next five years. The report explores ...
November 2015 | $12800 | View Details >>
This new report from VPGMarketResearch.com provides an overview of the Japanese diagnostic testing market, including sales and market shares of leading reagent and instrument suppliers, as well as test volume and sales forecasts for the following market segments: - Blood Banking - Cancer - Chemistry - Coagulation - ...
November 2016 | $0 | View Details >>
UPCOMING MARKET RESEARCH REPORTS
2017 © Copyright Big Market Research